Menley & James
This article was originally published in The Tan Sheet
Executive Summary
Cancels direct detailing marketing partnership with Kabi Pharmacia for bulk laxative Serutan due to a "conflict" that has arisen as a result of Kabi's recent merger with Adria Labs, Menley & James said Nov. 3. Initiated in January 1993, the joint venture was intended to enlarge Menley & James' Serutan physician and pharmacist detailing force to nearly 50,000. The firm currently has a detailing force of between 5,000 and 6,000. Menley & James said it is considering alternative detailing programs for Serutan.